76742-48-8Relevant articles and documents
Steric interference on the redox-conjugated pyrimidine ring rotation of monoand dinuclear copper complexes with (4-Methyl-2-pyrimidinyl)imine ligands
Hattori, Yohei,Nishikawa, Michihiro,Kusamoto, Tetsuro,Kume, Shoko,Nishihara, Hiroshi
, p. 1037 - 1039 (2014)
A mononuclear copper(I) complex with N-[(4-methyl-2- pyrimidinyl)methylene] -p-toluidine (1?BF4) and a dinuclear copper(I) complex with N,N'-bis[(4-methyl-2-pyrimidinyl)- methylene]-p-phenylenediamine (2?(BF4)2) were synth
MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2
-
Page/Page column 74, (2021/08/06)
The present application provides a compound of Formula: or a pharmaceutically acceptable salt thereof, wherein ring B, L1, ring A, L2, n, R1, R2, R3, R4, and X1 are as described herein. Pharmaceutical compositions comprising the compound, as well as the methods of making and using the compound, are also provided.
ISOQUINOLINE COMPOUNDS AND USES THEREOF
-
Paragraph 0281-0282; 0317, (2020/02/16)
Isoquinoline compounds of formula (I) variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the isoquinoline compounds.